The emergence of multidrug-resistant bacteria in clinical settings continues to challenge modern medicine, with particular concern arising when newly identified bacterial species demonstrate extensive antibiotic resistance capabilities. This development threatens the effectiveness of standard treatment protocols and highlights gaps in current microbial identification systems.
Irish researchers have documented the first clinical cases of patient colonization with Phytobacter species carrying multiple resistance genes, including carbapenemase-encoding elements. Two distinct strains, P. diazotrophicus and P. ursingii, were isolated from rectal swabs and found to harbor plasmid-borne resistance genes including blaIMP-4, blaSHV-12, and mcr-9.1. Genomic analysis revealed these bacteria resist aztreonam, multiple antibiotic classes including aminoglycosides and fluoroquinolones, while maintaining sensitivity to carbapenems and colistin. The strains carried IncHI2A plasmids, mobile genetic elements that can transfer resistance traits between bacterial species.
This finding represents a significant clinical concern because Phytobacter is frequently misidentified in standard laboratory testing, potentially leading to inappropriate treatment decisions. The genus belongs to Enterobacterales, a family that includes many common pathogens, yet current identification systems often fail to distinguish these species accurately. Genomic surveys reveal that over one-quarter of known Phytobacter strains carry carbapenemase genes, with nearly 30% harboring disinfectant resistance mechanisms. The co-occurrence of multiple resistance genes on transferable plasmids suggests these bacteria could serve as reservoirs for spreading antibiotic resistance to other pathogens. While these cases involved asymptomatic colonization rather than active infection, the presence of such extensively resistant organisms in clinical settings warrants enhanced surveillance and improved diagnostic capabilities.